tiprankstipranks
Trending News
More News >
Kobayashi Pharmaceutical Co (JP:4967)
:4967

Kobayashi Pharmaceutical Co (4967) Price & Analysis

Compare
0 Followers

4967 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

2.36%93.26%
Insiders
2.36%
Mutual Funds
― Other Institutional Investors
93.26% Public Companies and
Individual Investors

4967 FAQ

What was Kobayashi Pharmaceutical Co ’s price range in the past 12 months?
Kobayashi Pharmaceutical Co lowest stock price was ¥4850.00 and its highest was ¥6350.00 in the past 12 months.
    What is Kobayashi Pharmaceutical Co ’s market cap?
    Kobayashi Pharmaceutical Co ’s market cap is ¥390.25B.
      When is Kobayashi Pharmaceutical Co ’s upcoming earnings report date?
      Kobayashi Pharmaceutical Co ’s upcoming earnings report date is Jul 31, 2025 which is in 24 days.
        How were Kobayashi Pharmaceutical Co ’s earnings last quarter?
        Kobayashi Pharmaceutical Co released its earnings results on May 09, 2025. The company reported ¥21.86 earnings per share for the quarter, missing the consensus estimate of ¥50.023 by -¥28.163.
          Is Kobayashi Pharmaceutical Co overvalued?
          According to Wall Street analysts Kobayashi Pharmaceutical Co ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Kobayashi Pharmaceutical Co pay dividends?
            Kobayashi Pharmaceutical Co pays a Semiannually dividend of ¥44 which represents an annual dividend yield of 1.67%. See more information on Kobayashi Pharmaceutical Co dividends here
              What is Kobayashi Pharmaceutical Co ’s EPS estimate?
              Kobayashi Pharmaceutical Co ’s EPS estimate is 24.03.
                How many shares outstanding does Kobayashi Pharmaceutical Co have?
                Kobayashi Pharmaceutical Co has 78,050,000 shares outstanding.
                  What happened to Kobayashi Pharmaceutical Co ’s price movement after its last earnings report?
                  Kobayashi Pharmaceutical Co reported an EPS of ¥21.86 in its last earnings report, missing expectations of ¥50.023. Following the earnings report the stock price went down -0.84%.
                    Which hedge fund is a major shareholder of Kobayashi Pharmaceutical Co ?
                    Currently, no hedge funds are holding shares in JP:4967

                    Company Description

                    Kobayashi Pharmaceutical Co

                    Kobayashi Pharmaceutical Co., Ltd. (TSE: 4967) is a leading Japanese company specializing in the development, manufacturing, and marketing of consumer healthcare products, pharmaceuticals, and medical devices. Established in 1919, the company operates in several sectors including over-the-counter (OTC) health products, household products, and medical devices. Kobayashi Pharmaceutical is renowned for its innovative approach to product development, with a diverse portfolio that includes pain relief products, gastrointestinal medications, sanitary products, and home care solutions.

                    4967 Stock 12 Month Forecast

                    Average Price Target

                    ¥5,096.79
                    ▼(-5.49%Downside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4843":"¥4,843","5732":"¥5,732","6621":"¥6,621","5287.5":"¥5,287.5","6176.5":"¥6,176.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5096.7928345824,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥5.10K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5096.7928345824,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥5.10K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5096.7928345824,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥5.10K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4843,5287.5,5732,6176.5,6621],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2024","6":"Jul<br/>2024","9":"Sep<br/>2024","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5246.205,5234.711756506338,5223.218513012677,5211.7252695190155,5200.232026025354,5188.738782531693,5177.245539038031,5165.752295544369,5154.259052050707,5142.7658085570465,5131.272565063385,5119.779321569723,5108.286078076062,{"y":5096.7928345824,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5246.205,5234.711756506338,5223.218513012677,5211.7252695190155,5200.232026025354,5188.738782531693,5177.245539038031,5165.752295544369,5154.259052050707,5142.7658085570465,5131.272565063385,5119.779321569723,5108.286078076062,{"y":5096.7928345824,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5246.205,5234.711756506338,5223.218513012677,5211.7252695190155,5200.232026025354,5188.738782531693,5177.245539038031,5165.752295544369,5154.259052050707,5142.7658085570465,5131.272565063385,5119.779321569723,5108.286078076062,{"y":5096.7928345824,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6620.046,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6556.673,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5832.27,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4844.626,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5284.337,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5293.112,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5206.87,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5800.257,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5466.231,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5466.231,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5432.829,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5455.498,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5246.205,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Paltac
                    Rohto Pharmaceutical Co
                    Pola Orbis Holdings
                    Kose
                    Lion
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis